| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |